Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
3.090
-0.070 (-2.22%)
Jun 5, 2026, 4:00 PM EDT - Market closed
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $6.69 million as of June 5, 2026. Its market cap has decreased by -58.37% in one year.
Market Cap
6.69M
Enterprise Value
-2.50M
1-Year Change
-58.37%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $6.69M, a decrease of -63.83%. That is a compound annual growth rate of -5.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 6.69M | -72.86% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiomX | 7.31M |
| Acurx Pharmaceuticals | 7.19M |
| Xenetic Biosciences | 7.08M |
| PMGC Holdings | 7.00M |
| Genprex | 6.85M |
| Processa Pharmaceuticals | 6.70M |
| Enveric Biosciences | 6.63M |
| SciSparc | 6.56M |